Mira Pharmaceuticals Inc (NASDAQ: MIRA) is 175.29% higher on its value in year-to-date trading and has touched a low of $0.58 and a high of $5.01 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MIRA stock was last observed hovering at around $1.28 in the last trading session, with the day’s gains setting it 0.26%.
Currently trading at $1.54, the stock is 25.00% and 22.13% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.88 million and changing 20.31% at the moment leaves the stock 28.15% off its SMA200. MIRA registered 35.09% gain for a year compared to 6-month loss of 15.79%. The firm has a 50-day simple moving average (SMA 50) of $1.261 and a 200-day simple moving average (SMA200) of $1.201715.
The stock witnessed a 27.27% gain in the last 1 month and extending the period to 3 months gives it a 82.55%, and is 33.91% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.62% over the week and 9.32% over the month.
Mira Pharmaceuticals Inc (MIRA) has around 5 employees, a market worth around $26.78M and $0.00M in sales. Distance from 52-week low is 165.47% and -69.26% from its 52-week high. The company has generated returns on investments over the last 12 months (-611.87%).
The EPS is expected to grow by 26.67% this year.
Mira Pharmaceuticals Inc (MIRA) Top Institutional Holders
18.0 institutions hold shares in Mira Pharmaceuticals Inc (MIRA), with institutional investors hold 7.13% of the company’s shares. The shares outstanding are 16.81M, and float is at 12.90M with Short Float at 1.81%. Institutions hold 5.72% of the Float.
The top institutional shareholder in the company is CROSS STAFF INVESTMENTS INC with over 0.38 million shares valued at $0.24 million. The investor’s holdings represent 2.5939% of the MIRA Shares outstanding. As of 2024-06-30, the second largest holder is AVANTAX PLANNING PARTNERS, INC. with 0.12 million shares valued at $75644.0 to account for 0.8034 of the shares outstanding. The other top investors are SUNCOAST EQUITY MANAGEMENT which holds 40000.0 shares representing 0.2706% and valued at over $25480.0, while UBS GROUP AG holds 0.1999 of the shares totaling 29546.0 with a market value of $18821.0.
Mira Pharmaceuticals Inc (MIRA) Insider Activity
The most recent transaction is an insider sale by Aminov Erez, the company’s Chief Executive Officer. SEC filings show that Aminov Erez sold 55,410 shares of the company’s common stock on Nov 19 ’24 at a price of $1.39 per share for a total of $77020.0. Following the sale, the insider now owns 1.11 million shares.
Mira Pharmaceuticals Inc disclosed in a document filed with the SEC on Nov 20 ’24 that Aminov Erez (Chief Executive Officer) sold a total of 44,590 shares of the company’s common stock. The trade occurred on Nov 20 ’24 and was made at $1.27 per share for $56629.0. Following the transaction, the insider now directly holds 1.06 million shares of the MIRA stock.
